Request Demo
Last update 26 Dec 2024
LCAR-HL30 cells(Nanjing Legend Biotech)
Last update 26 Dec 2024
Overview
Basic Info
Drug Type CAR-T |
Synonyms CD30-Targeted LCAR-HL30 Cells(Nanjing Legend Biotech) |
Target |
Mechanism CD30 modulators(Tumor necrosis factor receptor superfamily member 8 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with LCAR-HL30 cells(Nanjing Legend Biotech)NCT06494371
An Open-label Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of CD30-Targeted LCAR-HL30 Cells in Patients With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma
100 Clinical Results associated with LCAR-HL30 cells(Nanjing Legend Biotech)
Login to view more data
100 Translational Medicine associated with LCAR-HL30 cells(Nanjing Legend Biotech)
Login to view more data
100 Patents (Medical) associated with LCAR-HL30 cells(Nanjing Legend Biotech)
Login to view more data
100 Deals associated with LCAR-HL30 cells(Nanjing Legend Biotech)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anaplastic Large-Cell Lymphoma | Phase 1 | CN | 01 Jul 2024 | |
| Refractory Hodgkin Lymphoma | Phase 1 | CN | 01 Jul 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free